205 related articles for article (PubMed ID: 27150670)
1. Can an electronic glycaemic notebook associated with an insulin calculator improve HbA1c in diabetic patients on a multiple insulin injections regimen? A 26-week observational real-life study.
Oriot P; Ponchon M; Hermans MP
Acta Clin Belg; 2016 Feb; 71(1):51-6. PubMed ID: 27150670
[TBL] [Abstract][Full Text] [Related]
2. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
3. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
4. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
5. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of carbohydrate counting versus other forms of dietary advice in patients with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials.
Builes-Montaño CE; Ortiz-Cano NA; Ramirez-Rincón A; Rojas-Henao NA
J Hum Nutr Diet; 2022 Dec; 35(6):1030-1042. PubMed ID: 35436364
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study.
Rabbone I; Scaramuzza AE; Ignaccolo MG; Tinti D; Sicignano S; Redaelli F; De Angelis L; Bosetti A; Zuccotti GV; Cerutti F
Diabetes Res Clin Pract; 2014 Mar; 103(3):388-94. PubMed ID: 24447811
[TBL] [Abstract][Full Text] [Related]
8. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
[TBL] [Abstract][Full Text] [Related]
9. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
Vinagre I; Álvarez P; García N; Roura G; Conget I;
Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
[TBL] [Abstract][Full Text] [Related]
10. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Wagner RS
BMC Fam Pract; 2012 Oct; 13():102. PubMed ID: 23062116
[TBL] [Abstract][Full Text] [Related]
11. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.
Sharplin P; Gordon J; Peters JR; Tetlow AP; Longman AJ; McEwan P
Cardiovasc Diabetol; 2009 Feb; 8():9. PubMed ID: 19220880
[TBL] [Abstract][Full Text] [Related]
12. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
[TBL] [Abstract][Full Text] [Related]
15. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients.
Nyomba BL; Berard L; Murphy LJ
Diabet Med; 2004 Feb; 21(2):129-35. PubMed ID: 14984447
[TBL] [Abstract][Full Text] [Related]
16. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
17. Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting.
McAdam-Marx C; Bouchard J; Aagren M; Nelson R; Brixner D
Diabetes Obes Metab; 2010 Jan; 12(1):54-64. PubMed ID: 19758356
[TBL] [Abstract][Full Text] [Related]
18. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
19. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
Davey B; Segal DG
S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
[TBL] [Abstract][Full Text] [Related]
20. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
